The Place of Enucleation and Enucleo-Resection in the Treatment of Pancreatic Metastasis of Renal Cell Carcinoma

  • Thierry Yazbek Department of Digestive Diseases, Montsouris Institute. Paris, France
  • Brice Gayet Department of Digestive Diseases, Montsouris Institute. Paris, France
Keywords: Carcinoma, Renal Cell, Nephrectomy, Pancreas, Pancreatectomy, Pancreaticoduodenectomy


Context Renal cell carcinoma has shown less response to systemic therapies including chemotherapy, radiotherapy and immunotherapy than other cancers. Metastasis of renal cell carcinoma to the pancreas occurs, even after long term radical nephrectomy, surgical resection remains the only potentially curative intervention. We performed surgery for pancreatic metastatic renal cell carcinoma and analyzed the results. Methods We retrospectively analyzed 11 patients who had undergone pancreatic resection or metastasectomy at our hospital from January 1994 to January 2010. Patient’s demographics, clinical variables, types of pancreatic resections (standard or atypical resection), primary histopathology, surgical outcomes, survival and disease free interval were examined. We compared the standard pancreatic resection to atypical resection (enucleation or enucleo-resection). Results Eleven patients underwent 14 pancreatic resections or metastasectomy (3 pancreaticoduodenectomy, 4 distal pancreatectomy, 1 completion of pancreatectomy, 4 enucleations and two enucleo-resections) for pancreatic renal cell carcinoma metastasis. The median age was 73 years, the median time period between nephrectomy and finding of pancreatic metastasis was 11.4 years. One patient showed synchronous pancreatic metastatic lesions on radiology. One patient died from a splenic artery pseudoaneurysm rupture 35 days after the surgery. Major complications occurred in 4 patients with standard resection (one hemoperitoneum, three pancreatic fistulas), and in one patient with atypical resection (duodenal fistula); six patients with standard resection presented postoperative diabetes mellitus. Median survival age was 6.5 years (range 1-9 years). Two patients died of metastatic disease 5 to 6 years, while 7 patients are alive and well 1 to 9 years after surgery. Conclusions According to these results and regardless of the small number of cases, atypical resection of metastatic renal cell carcinoma has a high median survival rate even after pancreatic recurrence or distant metastasis. It seems reasonable to favor a good quality of life and less diabetes with a limited atypical resection.

Image: Institut Mutualiste Montsouris. Paris, France.


Download data is not yet available.


Jemal A, Siegel R, Xu J, Ward E Cancer Statistics, 2010. CA Cancer J Clin 2010; 60(5):277-300. [PMID 20610543]

Mihály Z, Sztupinszki Z, Surowiak P, Győrffy B. A comprehensive overview of targeted therapy in metastatic renal cell carcinoma. Curr Cancer Drug Targets. 2012 May 14. [PMID 22515521]

Maldazys JD, deKernion JB. Prognostic factors in metastatic renal carcinoma. J Urol 1986; 136(2):376-9. [PMID 3735498]

McNichols DW, Segura JW, DeWeerd JH. Renal cell carcinoma: long-term survival and late recurrence. J Urol 1981; 126(1):17-23. [PMID 7253072]

Bassi C, Butturini G, Falconi M, Sargenti M, Mantovani W, Pederzoli P. High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma. Br J Surg 2003; 90(5):555-9. [PMID 12734861]

Sellner F, Tykalsky N, De Santis M, Pont J, Klimpfinger M. Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: an indication for pancreatic surgery. Ann Surg Oncol 2006; 13(1):75-85. [PMID 16372157]

Thompson LD, Heffess CS. Renal Cell Carcinoma to the pancreas in surgical pathology material. Cancer 2000; 89:1076-1088. [PMID 10964338]

Yokonishi T, Ito Y, Osaka K, Komiya A, Kobayashi K, et al. Pancreatic metastasis from renal cell carcinoma 25 years after radical nephrectomy. Hinyokika Kiyo 2010; 56(11):629-33. [PMID 21187708]

Zerbi A, Ortolano E, Balzano G, Borri A, Beneduce AA, Di Carlo V. Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann Surg Oncol 2008; 15(4):1161-8. [PMID 18196343]

Faure JP, Tuech JJ, Richer JP, Pessaux P, Arnaud JP, Carretier M. Pancreatic metastasis of renal cell carcinoma: presentation, treatment and survival. J Urol 2001; 165(1):20-2. [PMID 11125354]

Sohn TA, Yeo CJ, Cameron JL, Nakeeb A, Lillemoe KD. Renal cell carcinoma metastatic to the pancreas: results of surgical management. J Gastrointest Surg 2001; 5(4):346-51. [PMID 11985973]

Demirjian AN, Vollmer CM, McDermott DF, Mullen JT, Atkins MB, Callery MP. Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreas. HPB 2009; 11(2):150-3. [PMID 19590640]

Law CH, Wei AC, Hanna SS, Al-Zahrani M, Taylor BR, Greig PD, Langer B, Gallinger S. Pancreatic resection for metastatic renal cell carcinoma: presentation, treatment, and outcome. Ann Surg Oncol 2003; 10(8):922-6. [PMID 14527912]

Sotiropoulos GC, Lang H, Liu C, Brokalaki EI, Molmenti E, Broelsch CE. Surgical treatment of pancreatic metastases of renal cell carcinoma. JOP. J Pancreas (Online) 2005 Jul 8;6(4):339-43. [PMID 16006684]

Kassabian A, Stein J, Jabbour N, Parsa K, Skinner D, Parekh D, Cosenza C, Selby R. Renal cell carcinoma metastatic to the pancreas: a single-institution series and review of the literature. Urology. 2000 Aug 1;56(2):211-5. [PMID 10925080]

Dekernion JB, Ramming KP, Smith RB. The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol (1978; 120(2):148-52. [PMID 78992]

Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996; 335:865-875. [PMID 8778606]

Sweeney AD, Fisher WE, Wu MF, Hilsenbeck SG, Brunicardi FC. Value of pancreatic resection for cancer metastatic to the pancreas. J Surg Res 2010; 160(2):268-76. [PMID 20422750]

Wente MN, Kleeff J, Esposito I, Hartel M, Müller MW, Fröhlich BE, et al. Renal cancer cell metastasis into the pancreas: a single-center experience and overview of the literature. Pancreas 2005; 30(3):218-22. [PMID 15782097]

Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138(1):8-13. [PMID 16003309]

Konstantinidis IT, Dursun A, Zheng H, Wargo JA, Thayer SP, Fernandez-del Castillo C, et al. Metastatic tumors in the pancreas in the modern era. J Am Coll Surg 2010; 211(6):749-53. [PMID 21109158]

Kobayashi A, Yamaguchi T, Ishihara T, Tadenuma H, Nakamura K, Ohshima T, et al. Spontaneous rupture of pancreatic metastasis from renal cell carcinoma. Jpn J Clin Oncol 2004; 34(11):696-9. [PMID 15613561]

Z'graggen K, Fernández-del Castillo C, Rattner DW, Sigala H, Warshaw AL. Metastases to the pancreas and their surgical extirpation. Arch Surg 1998; 133(4):413-7; discussion 418-9. [PMID 9565122]

Ballarin R, Spaggiari M, Cautero N, De Ruvo N, Montalti R, Longo C, et al. Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol 2011; 17(43):4747-56. [PMID 22147975]

Reddy S, Edil BH, Cameron JL, Pawlik TM, Herman JM, Gilson MM, et al. Pancreatic resection of isolated metastases from nonpancreatic primary cancers. Ann Surg Oncol 2008 Nov;15(11):3199-206. [PMID 18784960]

Akashi Y, Saiura A, Kishi Y, Koga R, Morimura R, Yoshioka R, et al. Outcome after surgical resection of isolated metastases to the pancreas. Hepatogastroenterology 2010; 57(104):1549-52. [PMID 21443119]

Cho IC, Chung J. Current status of targeted therapy for advanced renal cell carcinoma. Korean J Urol. 2012 Apr;53(4):217-28. [PMID 22536463]

Itsumi M, Tatsugami K. Immunotherapy for renal cell carcinoma. Clin Dev Immunol 2010:284581. [PMID 21253521]

Institut Mutualiste Montsouris. Paris, France
How to Cite
YazbekT., & GayetB. (2012). The Place of Enucleation and Enucleo-Resection in the Treatment of Pancreatic Metastasis of Renal Cell Carcinoma. JOP. Journal of the Pancreas, 13(4), 433-438.